FDA (Drugs) recall action 62511

Lloyd Inc. of Iowa recalled 12 products on 2012-12-12

The FDA (Drugs) publishes a recall like this one as 12 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 12 pages.

Products: 12
Announced: 2012-12-12
Critical: 0
Units: 17,165,473

Why these products were recalled

cGMP Deviations; does not meet in process specification requirements

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–12 of 12

ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to Manufacturing Deviations
Lloyd Inc. of Iowa is recalling specific lots of Levothroid tablets because they failed to meet in-process specification requirements.
Product
Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling specific lots of Levothroid (levothyroxine sodium) tablets because they do not meet in-process specification requirements.
Product
Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab 0.125 mg. Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 1,924,174 tablets of Thyro-Tab 0.125 mg. (Lot #HB27811) because the product does not meet in-process specification requirements.
Product
Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab 0.088 mg. Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab 0.088 mg. tablets because they do not meet in-process specification requirements.
Product
Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to Manufacturing Deviations
Lloyd Inc. of Iowa is recalling specific bottles of Levothroid tablets because they failed to meet in-process specification requirements during manufacturing.
Product
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab Tablets Due to Manufacturing Deviations
Lloyd Inc. of Iowa is recalling 1.9 million Thyro-Tab tablets because they failed to meet in-process specification requirements.
Product
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets because they do not meet in-process specification requirements.
Product
Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets because they do not meet in-process specification requirements due to cGMP deviations.
Product
Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab 0.300 mg Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 1,902,957 Thyro-Tab 0.300 mg tablets because they do not meet in-process specification requirements.
Product
Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab 0.112 mg tablets because they do not meet in-process specification requirements.
Product
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets because they do not meet in-process specification requirements.
Product
Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state
ModerateFDA (Drugs)··2012-12-12
Lloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 3.7 million Thyro-Tab tablets because they do not meet in-process specification requirements and involve cGMP deviations.
Product
Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Distribution
1 state